Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

LT1001 (Naldebain(R)), an Extended-Release Analgesic Injection, Received Its Second Approval from Singapore's HSA

prnasiaDecember 23, 2020

Tag: LT1001 , Lumosa , extended-release analgesic injection , HSA

PharmaSources Customer Service